Literature DB >> 15004691

Amyloid fibrils from the viewpoint of protein folding.

S Ohnishi1, K Takano2.   

Abstract

In amyloid related diseases, proteins form fibrillar aggregates with highly ordered beta-sheet structure regardless of their native conformations. Formation of such amyloid fibrils can be reproducible in vitro using isolated proteins/peptides, suggesting that amyloid fibril formation takes place as a result of protein conformational change. In vitro studies revealed that perturbation of the native structure is important for the fibril formation, and it is suggested that the mechanisms of amyloid fibril formation share the mechanisms of protein folding. In particular, amyloid fibril formation is similar to one of the common features of proteins, i.e. amorphous aggregation upon partial unfolding, which is likely driven by hydrophobic interactions through exposed protein interior. However, these molecular associations are distinct phenomena, and identifying factors that lead to amyloid fibril formation would precede our understanding of the mechanisms of amyloid fibrillization. The necessity of understanding the nature of protein denatured states is also suggested.

Mesh:

Substances:

Year:  2004        PMID: 15004691     DOI: 10.1007/s00018-003-3264-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  14 in total

1.  Rapid pacing to facilitate transcatheter prosthetic heart valve implantation.

Authors:  John G Webb; Sanjeevan Pasupati; Leslie Achtem; Christopher R Thompson
Journal:  Catheter Cardiovasc Interv       Date:  2006-08       Impact factor: 2.692

2.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

3.  Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Alec Vahanian; Ottavio R Alfieri; Nawwar Al-Attar; Manuel J Antunes; Jeroen Bax; Bertrand Cormier; Alain Cribier; Peter De Jaegere; Gerard Fournial; Arie Pieter Kappetein; Jan Kovac; Susanne Ludgate; Francesco Maisano; Neil Moat; Friedrich-Wilhelm Mohr; Patrick Nataf; Luc Pierard; José Luis Pomar; Joachim Schofer; Pilar Tornos; Murat Tuzcu; Ben van Hout; Ludwig K von Segesser; Thomas Walther
Journal:  Eur J Cardiothorac Surg       Date:  2008-05-27       Impact factor: 4.191

4.  Transapical minimally invasive aortic valve implantation: multicenter experience.

Authors:  Thomas Walther; Paul Simon; Todd Dewey; Gerhard Wimmer-Greinecker; Volkmar Falk; Marie T Kasimir; Mirko Doss; Michael A Borger; Gerhard Schuler; Dietmar Glogar; Wolfgang Fehske; Ernst Wolner; Friedrich W Mohr; Michael Mack
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

5.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

6.  Percutaneous suture closure for management of large French size arterial puncture in aortic valvuloplasty.

Authors:  L W Solomon; B Fusman; N Jolly; A Kim; T Feldman
Journal:  J Invasive Cardiol       Date:  2001-08       Impact factor: 2.022

Review 7.  Percutaneous transcatheter aortic valve implantation: Evolution of the technology.

Authors:  Paul T L Chiam; Carlos E Ruiz
Journal:  Am Heart J       Date:  2009-02       Impact factor: 4.749

8.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis.

Authors:  Alain Cribier; Hélène Eltchaninoff; Christophe Tron; Fabrice Bauer; Carla Agatiello; Laurent Sebagh; Assaf Bash; Danielle Nusimovici; P Y Litzler; Jean-Paul Bessou; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2004-02-18       Impact factor: 24.094

9.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience.

Authors:  Alain Cribier; Helene Eltchaninoff; Christophe Tron; Fabrice Bauer; Carla Agatiello; Deborah Nercolini; Sydney Tapiero; Pierre-Yves Litzler; Jean-Paul Bessou; Vasilis Babaliaros
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

10.  Transapical aortic valve implantation: step by step.

Authors:  Thomas Walther; Todd Dewey; Michael A Borger; Jörg Kempfert; Axel Linke; Reinhardt Becht; Volkmar Falk; Gerhard Schuler; Friedrich W Mohr; Michael Mack
Journal:  Ann Thorac Surg       Date:  2009-01       Impact factor: 4.330

View more
  28 in total

1.  The effects of molecular crowding on the amyloid fibril formation of alpha-lactalbumin and the chaperone action of alpha-casein.

Authors:  Arezou Ghahghaei; Adeleh Divsalar; Nasim Faridi
Journal:  Protein J       Date:  2010-05       Impact factor: 2.371

Review 2.  Casting a net on dendritic spines: the extracellular matrix and its receptors.

Authors:  Lorraine E Dansie; Iryna M Ethell
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

3.  Toward an accurate theoretical framework for describing ensembles for proteins under strongly denaturing conditions.

Authors:  Hoang T Tran; Rohit V Pappu
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

Review 4.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

Review 5.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

Review 6.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 7.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22

8.  A Caenorhabditis elegans model system for amylopathy study.

Authors:  Zhibing Duan; Federico Sesti
Journal:  J Vis Exp       Date:  2013-05-17       Impact factor: 1.355

9.  Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress.

Authors:  R L Hull; S Zraika; J Udayasankar; K Aston-Mourney; S L Subramanian; S E Kahn
Journal:  Diabetologia       Date:  2009-04-08       Impact factor: 10.122

10.  Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28).

Authors:  Christine Talmard; Rodrigue Leuma Yona; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2008-12-13       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.